{"nct_id":"NCT02684617","title":"Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155)","status":"TERMINATED","status_verified_date":"2021-02","start_date":"2016-03-29","start_date_type":"ACTUAL","primary_completion_date":"2020-04-06","primary_completion_date_type":"ACTUAL","completion_date":"2020-04-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}